Unknown

Dataset Information

0

Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.


ABSTRACT: The worldwide diversity of HIV-1 presents an unprecedented challenge for vaccine development. Antigens derived from natural HIV-1 sequences have elicited only a limited breadth of cellular immune responses in nonhuman primate studies and clinical trials to date. Polyvalent 'mosaic' antigens, in contrast, are designed to optimize cellular immunologic coverage of global HIV-1 sequence diversity. Here we show that mosaic HIV-1 Gag, Pol and Env antigens expressed by recombinant, replication-incompetent adenovirus serotype 26 vectors markedly augmented both the breadth and depth without compromising the magnitude of antigen-specific T lymphocyte responses as compared with consensus or natural sequence HIV-1 antigens in rhesus monkeys. Polyvalent mosaic antigens therefore represent a promising strategy to expand cellular immunologic vaccine coverage for genetically diverse pathogens such as HIV-1.

SUBMITTER: Barouch DH 

PROVIDER: S-EPMC2834868 | BioStudies | 2010-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2012-01-01 | S-EPMC3582221 | BioStudies
2009-01-01 | S-EPMC2643734 | BioStudies
2010-01-01 | S-EPMC2834806 | BioStudies
1000-01-01 | S-EPMC4817818 | BioStudies
1000-01-01 | S-EPMC5149708 | BioStudies
2013-01-01 | S-EPMC3846288 | BioStudies
1000-01-01 | S-EPMC5050445 | BioStudies
2012-01-01 | S-EPMC3463593 | BioStudies
2020-01-01 | S-EPMC6997759 | BioStudies
2010-01-01 | S-EPMC2984153 | BioStudies